Abstract: An apparatus for blocking the electric activity of an area of tissue, comprises circuitry (S) for creating a long non-excitatory electric signal between at least two points (R1, R2) located in the vicinity of a muscle.
Abstract: Implantable cardiac monitoring and stimulation devices and methods using cardiac leads employ coated fixation arrangements. The coating, such as an expanded polytetrafluoroethylene, reduces exit block by reducing the tissue response to the fixation arrangement, decreasing the amount of fibrotic tissue, and reducing exit block. An epicardial lead may include a lead body with one or more electrical conductors with associated insulators and an electrode assembly situated at the distal end. The electrode assembly includes an electrode having an active fixation arrangement such as a helical fixation element. The fixation arrangement is completely or partially coated with a fluoropolymer or has a sleeve on some or all of the active fixation arrangement. The coating or sleeve may include a steroid or other pharmacological eluting arrangement disposed on the active fixation arrangement.
Abstract: Various methods and devices are disclosed for improving cardiac function in hearts having zones of infarcted (akinetic) and aneurysmal (dyskinetic) tissue regions. The methods and devices reduce the radius of curvature in walls of the heart proximal infarcted and aneurysmal regions to reduce wall stress and improve pumping efficiency. The inventive methods and related devices include splinting of the chamber wall proximal the infarcted region and various other devices and methods including suture and patch techniques.
Type:
Grant
Filed:
May 2, 2002
Date of Patent:
March 13, 2007
Assignee:
Myocor, Inc.
Inventors:
Patrick M. McCarthy, Cyril J. Schweich, Jr., Todd J. Mortier, Peter T. Keith, Michael J. Kallok
Abstract: An implantable medical device, such as an implantable pulse generator (IPG) used with a spinal cord stimulation (SCS) system, includes a rechargeable lithiumion battery having an anode electrode with a substrate made substantially from titanium. Such battery construction allows the rechargeable battery to be discharged down to zero volts without damage to the battery. The implantable medical device includes battery charging and protection circuitry that controls the charging of the battery so as to assure its reliable and safe operation. A multi-rate charge algorithm is employed that minimizes charging time while ensuring the battery cell is safely charged. Fast charging occurs at safer lower battery voltages (e.g., battery voltage above about 2.5 V), and slower charging occurs when the battery nears full charge higher battery voltages (e.g., above about 4.0 V). When potentially less-than-safe very low voltages are encountered (e.g., less than 2.
Type:
Grant
Filed:
April 18, 2003
Date of Patent:
February 13, 2007
Assignee:
Advanced Bionics Corporation
Inventors:
Paul M Meadows, Carla Mann Woods, Hisashi Tsukamoto, Joey Chen
Abstract: An adapter system is provided for adapting and connecting a leadless microstimulator to a separate monopolar, bipolar, or tripolar electrode. Advantageously, the microstimulator does not need to be physically modified. The adapter system encloses the microstimulator and electrically connects the microstimulator to the selected, separate electrode via an extension lead or leads. The adapter has two forms: a monopolar adapter having a single opening or a bipolar adapter having two openings. The separate electrode is equipped with at least one extension lead having a connector that can be inserted into the opening of the monopolar adapter or the bipolar adapter and connect to the microstimulator that is placed within the monopolar or bipolar adapter.
Abstract: A flexible catheter shaft with a balloon on the distal section suitable for inserting into a body of a patient comprising a deflectable, high torque transmission assembly of a slit tubular element that has either a plurality of rows of slits with anchors or at least one continuously spiraling slit on said slit tubular element and has sufficient bending and torque properties ensuring that a substantial fraction of the bending, rotational and displacement forces provided along said flexible catheter shaft are translated to bending, rotational and displacement forces at a distal end of said flexible catheter shaft, facilitating the placement of the catheter distal section and using the balloon for blocking the vessel ostium and injecting contrast medium through an open distal tip.
Type:
Grant
Filed:
August 25, 2003
Date of Patent:
January 30, 2007
Assignee:
Irvine Biomedical Inc.
Inventors:
Cary Hata, Alan de la Rama, Weng-Kwen Raymond Chia
Abstract: In a cochlear implant system, the implantable stimulator includes a monitor which monitors parameters associated with the stimulation signals and/or the power stored in an energy storage element which stores energy transmitted from the processor. This parameter or parameters is/are analyzed and one or more feedback signals are generated and transmitted back to the processor. The processor uses the feedback signal to insure that power is transmitted to the stimulator optimally and that the stimulation signals are compliant.
Abstract: A technique and associated device for stimulating multiple electrodes with multiple electrical signals in multiple regions of the spine without injury to the patient. The electrodes are applied to respective sides of the patient's spine, and a first electrical signal is applied to any electrodes in a treatment area of the lumbar region of the patient's spine, a second electrical signal is applied to any electrodes in a treatment area of the thoracic region of the patient's spine, and a third electrical signal is applied to any electrodes in a treatment area of the cervical region of the patient's spine to induce osteogenesis in at least one of the respective treated area's of the patient's spine. The first, second, and third electrical signals respectively generate different electrode currents in the respective treated areas and are ideally selected to create current densities that are approximately equal in respective treatment areas.
Type:
Grant
Filed:
July 2, 2002
Date of Patent:
January 23, 2007
Assignee:
The Trustees of the University of Pennsylvania
Abstract: A method and apparatus for treatment of heart failure, hypertension and renal failure by stimulating the renal nerve. The goal of therapy is to reduce sympathetic activity of the renal nerve. Therapy is accomplished by at least partially blocking the nerve with drug infusion or electrostimulation. Apparatus can be permanently implanted or catheter based.
Abstract: In a medical treatment device implanted within the body of a patient, a system and method using volatile and non-volatile memory devices within an implanted drug infusion pump to provide a safe and robust programmable system, able to back-up and restore the device's hardware and software operating parameters in the event of RAM corruption and as an alternative to hardware trim techniques. The pump includes a processor, a ROM, a RAM, and an EEPROM. The RAM serves as a main memory and the EEPROM serves a back-up memory in the event of RAM corruption. The ROM serves as an additional layer of back-up memory in the event of RAM and EEPROM corruption.
Abstract: A technique and device for preventing and/or treating osteoporosis, hip and spine fractures, and/or spine fusions by incorporating at least one conductive coil (110) into a garment (90) adapted to be worn adjacent to the patient's skin over a treatment area and applying an electrical signal to the coil effective to produce a magnetic flux the penetrates the treatment area so as to produce an electric field in the bones and the treatment area.
Type:
Grant
Filed:
July 10, 2002
Date of Patent:
January 2, 2007
Assignee:
The Trustees of the University of Pennsylvania
Abstract: Treatment of hypertension includes implantation of the discharge portion(s) of a catheter and/or electrical stimulation electrode(s) adjacent the tissue(s) to be stimulated. Stimulation pulses, i.e., drug infusion pulses and/or electrical pulses, are supplied by one or more implanted stimulators, through the catheter and possibly also a lead, tunneled subcutaneously between the stimulator and stimulation site. A microstimulator(s) may also/instead deliver electrical stimulation pulses. Stimulation sites include the carotid sinus and carotid body, among other locations. Treatments include drugs used for acute and/or chronic treatment of hypertension. In a number of embodiments, a need for or response to treatment is sensed, and the electrical and/or infusion pulses adjusted accordingly.
Type:
Grant
Filed:
January 16, 2003
Date of Patent:
December 26, 2006
Assignee:
Advanced Bionics Corporation
Inventors:
Todd K Whitehurst, Kelly H. McClure, James R Thacker, James P McGivern
Abstract: Alpha rhythm brain waves are related to mental and physical relaxation and healing. Based on the studies of bionics, this invention relates to inducing oscillatory alpha rhythm to the human body, and relates to the means of the alpha rhythm machine applied to human body. Research of the alpha rhythm of human brain wave patterns and EEG has indicated special recorded data of alpha rhythm brain waveform which is the bearing of the proper biological information of relaxing and healing. The apparatus was developed and built to construct and release the simulated human brain alpha rhythm signals which are at the frequencies ranging 8 Hz–14 Hz and at the amplitudes altered in high or low. Both the frequencies and the amplitudes are changing at a non-stationary random order in the duration of the event, respectively.
Abstract: A system for treating the heart includes a cardiac harness associated with a cardiac rhythm management devise which includes at least electrodes and a power source. The cardiac harness applies a compressive force on the heart during diastole and systole. The electrodes will deliver an electrical shock to the heart for defibrillation and/or can be used for pacing/sensing. The cardiac harness and electrodes are delivered and implanted on the heart by minimally invasive access.
Type:
Grant
Filed:
November 7, 2003
Date of Patent:
December 26, 2006
Assignee:
Paracor Medical, Inc.
Inventors:
Lilip Lau, Matthew G. Fishler, Craig Mar
Abstract: An image is captured or otherwise converted into a signal in an artificial vision system. The signal is transmitted to the retina utilizing an implant. The implant consists of a polymer substrate made of a compliant material such as poly(dimethylsiloxane) or PDMS. The polymer substrate is conformable to the shape of the retina. Electrodes and conductive leads are embedded in the polymer substrate. The conductive leads and the electrodes transmit the signal representing the image to the cells in the retina. The signal representing the image stimulates cells in the retina.
Type:
Grant
Filed:
November 16, 2001
Date of Patent:
December 5, 2006
Assignee:
The Regents of the University of California
Inventors:
Peter Krulevitch, Dennis L. Polla, Mariam N. Maghribi, Julie Hamilton
Abstract: The following disclosure describes several methods and apparatus for intracranial electrical stimulation to treat or otherwise effectuate a change in neural-functions of a patient. Several embodiments of methods in accordance with the invention are directed toward enhancing or otherwise inducing a lasting change in neural activity to effectuate a particular neural-function. Such lasting change in neural activity is defined as “neuroplasticity.” The methods in accordance with the invention can be used to treat brain damage (e.g., stroke, trauma, etc.), brain disease (e.g., Alzheimer's, Pick's, Parkinson's, etc.), and/or brain disorders (e.g., epilepsy, depression, etc.). The methods in accordance with the invention can also be used to enhance neural-function of normal, healthy brains (e.g., learning, memory, etc.), or to control sensory functions (e.g., pain).
Type:
Grant
Filed:
February 7, 2002
Date of Patent:
December 5, 2006
Assignee:
Northstar Neuroscience, Inc.
Inventors:
Andrew D. Firlik, Alan J. Levy, Bradford Evan Gliner
Abstract: Methods for using blood pumps to treat heart failure are disclosed. The pump is mounted on an interior of a stent, and the stent is releasably mounted on a distal end of a catheter. The distal end of the catheter is inserted into a peripheral artery and advanced to position at a region of interest within the descending aorta, the ascending aorta, or the left ventricle. The stent and the pump are released from the catheter, and the pump is activated to increase blood flow downstream of the pump. The pump can also be positioned in the vena cava or used to treat right-sided heart failure following the insertion of an LVAD, or to improve venous return in patients with varicose veins. Non-stent pumps are described for insertion between the pulmonary vein and aorta, and between the vena cava and pulmonary artery designed for use during cardiac surgery.
Type:
Grant
Filed:
October 28, 2002
Date of Patent:
December 5, 2006
Inventors:
Denise R. Barbut, Russell H. Patterson, Murk-Hein Heinemann
Abstract: The apparatus and method are designed to compute the optimal spatial and temporal characteristics for combating tumor growth within a body on the basis of cytological (as provided by biopsies, etc.) and anatomical data (as provided by CT, MRI, PET, etc.), as well as the electric properties of the different elements. On the basis of this computation, the apparatus applies the fields that have maximal effect on the tumor and minimal effect on all other tissues by adjusting both the field generator output characteristics and by optimal positioning of the insulated electrodes or isolects on the patient's body.
Abstract: A device for muscle stimulation, including: two exoskeletal shells, each including an outer member including an at least semi-rigid material, the shells being configured to at least partly, surround a limb portion of a user, and kinematic connection means connecting the shells and providing the shells with at least one degree of freedom in translation, so as to enable the shells to move in a substantially linear movement with respect to each other.
Type:
Grant
Filed:
September 30, 2002
Date of Patent:
December 5, 2006
Assignee:
N.E.S.S. Neuromuscular Electrical Stimulation Systems Ltd.
Abstract: A method and apparatus for forecasting and controlling neurological abnormalities in humans such as seizures or other brain disturbances. The system is based on a multi-level control strategy. Using as inputs one or more types of physiological measures such as brain electrical, chemical or magnetic activity, heart rate, pupil dilation, eye movement, temperature, chemical concentration of certain substances, a feature set is selected off-line from a pre-programmed feature library contained in a high level controller within a supervisory control architecture. This high level controller stores the feature library within a notebook or external PC. The supervisory control also contains a knowledge base that is continuously updated at discrete steps with the feedback information coming from an implantable device where the selected feature set (feature vector) is implemented.
Type:
Grant
Filed:
February 4, 2003
Date of Patent:
December 5, 2006
Assignee:
The Trustees of the University of Pennsylvania
Inventors:
Rosana Esteller, Javier Ramón Echauz, Brian Litt, George John Vachtsevanos